Haplo NK
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Haplo NK, covering 2018-01-10 to 2020-11-27. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-3.033: Haplo NK With SQ ALT-803 for Adults With Relapsed or Refractory AML [Phase 2]